Success of teamwork: diagnosis and personalized treatment of advanced rectal carcinoma - case presentation

1. Liu L, Zhu K, Yu W, Zhang S, Teng G, Guo J. Detection Rate, Anatomic Sites, and Pathologic Types of Colorectal Cancer During Colonoscopy Procedures. Surg Laparosc Endosc Percutan Tech. 2017; 27(5):394-399.10.1097/SLE.000000000000045628906418Search in Google Scholar

2. Shen F, Cui J, Cai K, Pan H, Bu H, Yu F. Prognostic accuracy of different lymph node staging systems in rectal adenocarcinoma with or without preoperative radiation therapy. Jpn J Clin Oncol. 2018; 1;48(7):625-632.10.1093/jjco/hyy07029788392Search in Google Scholar

3. Bochis OV, Fekete Z, Vlad C, Fetica B, Leucuta DC, Busuioc CI, Irimie A. The importance of a multidisciplinary team in rectal cancer management. Clujul Med. 2017; 90(3):279–285.10.15386/cjmed-689553620728781524Search in Google Scholar

4. Fulop ZZ, Gurzu S, Bara T, Dragus E, Bara T Jr, Voidazan S, Banias L, Jung I. Lymph node ratio, an independent prognostic factor for patients with stage II-III rectal carcinoma. Pathol Res Pract. 2019; 215(6):152384.10.1016/j.prp.2019.03.01330910253Search in Google Scholar

5. Fazeli MS, Keramati MR. Rectal cancer: a review. Med J Islam Repub Iran. 2015; 29: 171.Search in Google Scholar

6. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, Colditz GA. Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2004; 20;108(3):433-42.10.1002/ijc.11540290321714648711Search in Google Scholar

7. Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med. 2012; 15;156(10):703-9.10.7326/0003-4819-156-10-201205150-0000622586009Search in Google Scholar

8. Stintzing S. Management of colorectal cancer. F1000Prime Rep2014, 6:108.10.12703/P6-108422972825580262Search in Google Scholar

9. National Comprehensive Cancer Network (NCCN), NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer Version 3.2018, National Comprehensive Cancer Network, 2018.Search in Google Scholar

10. Zuo ZG, Zhang XF, Wang H, Liu QZ, Ye XZ, Xu C, Wu XB, Cai JH, Zhou ZH, Li JL, Song HY, Luo ZQ, Li P, Ni SC, Jiang L. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision. Medicine (Baltimore). 2016; 95(9):e2988.10.1097/MD.0000000000002988478290226945418Search in Google Scholar

11. Chandrasinghe PC, Ediriweera DS, Hewavisenthi J, Kumarage S, Deen KI. Total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer. Indian J Gastroenterol. 2014; 33(3):249-53.10.1007/s12664-013-0406-224048680Search in Google Scholar

12. Rivadulla-Serrano MI, Martínez-Ramos D, Armengol-Carrasco M, Escrig-Sos J, Paiva-Coronel GA, Fortea-Sanchís C, Salvador-Sanchís JL. Impact of the total number of harvested lymph nodes after colon cancer resections on survival in patients without involved lymph node. Rev Esp Enferm Dig. 2010; 102(5):296-301.10.4321/S1130-0108201000050000220524756Search in Google Scholar

13. Sclafani F, Wilson SH, Cunningham D, Gonzalez De Castro D, Kalaitzaki E, Begum R, Wotherspoon A, Capdevila J, Glimelius B, Roselló S, Thomas J, Tait D, Brown G, Oates J, Chau I. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. Int J Cancer. 2020; 1;146(1):94-102.10.1002/ijc.32507Search in Google Scholar

14. Wojas-Krawczyk K, Kalinka-Warzocha E, Reszka K, Nicoś M, Szumiło J, Mańdziuk S, Szczepaniak K, Kupnicka D, Lewandowski R, Milanowski J, Krawczyk P. Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study. Adv Clin Exp Med. 2019; 28(1):67-73.10.17219/acem/76162Search in Google Scholar

15. Ágoston EI, Baranyai Z, Dede K, Bodoky G, Kulka J, Bursics A, Harsányi L, Szász AM. Occurrence, intratumoral heterogeneity, prognostic and predictive potential of microsatellite instability following surgical resection of primary colorectal carcinomas and corresponding liver metastases. Orv Hetil. 2015; 6;156(36):1460-71.Search in Google Scholar

16. Stanczak A, Stec R, Bodnar L, Olszewski W, Cichowicz M, Kozlowski W, Szczylik C, Pietrucha T, Wieczorek M, Lamparska-Przybysz M. Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma. Pathol Oncol Res. 2011; 17(4):955-63.10.1007/s12253-011-9409-4Search in Google Scholar

17. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008; 134(5):1296-310.10.1053/j.gastro.2008.02.098Search in Google Scholar

18. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009; 7;373(9666):811-20.10.1016/S0140-6736(09)60484-0Search in Google Scholar